Promising horizons in achondroplasia along with the development of new drugs-Reference-Cited by-同舟云学术

Promising horizons in achondroplasia along with the development of new drugs

Published:2024 Issue:7 Volume:71 Page:643-650
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Ozono Keiichi¹²^ORCID,Kubota Takuo²^ORCID,Michigami Toshimi³^ORCID

Affiliation:

1. Center for Promoting Treatment of Intractable Diseases, Iseikai International General Hospital, Osaka 530-0052, Japan

2. Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan

3. Department of Bone and Mineral Research, Research Institute, Osaka Women’s and Children’s Hospital, Osaka Prefectural Hospital Organization, Osaka 594-1101, Japan

Publisher

Japan Endocrine Society

Link

https://www.jstage.jst.go.jp/article/endocrj/71/7/71_EJ24-0109/_pdf

Reference72 articles.

1. 1 Horton WA, Hall JG, Hecht JT (2007) Achondroplasia. Lancet 370: 162–172.

2. 2 Legare JM (1998) Achondroplasia. [updated May 11, 2023]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, et al. (eds) GeneReviews^® [Internet]. University of Washington, Seattle, USA: 1993–2024.

3. 3 Waller DK, Correa A, Vo TM, Wang Y, Hobbs C, et al. (2008) The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US. Am J Med Genet A 146A: 2385–2389.

4. 4 Coi A, Santoro M, Garne E, Pierini A, Addor MC, et al. (2019) Epidemiology of achondroplasia: a population-based study in Europe. Am J Med Genet A 179: 1791–1798.

5. 5 Foreman PK, van Kessel F, van Hoorn R, van den Bosch J, Shediac R, et al. (2020) Birth prevalence of achondroplasia: a systematic literature review and meta-analysis. Am J Med Genet A 182: 2297–2316.